Results 251 to 260 of about 139,090 (312)

Treatment‐Related Adverse Events and Health‐Related Quality of Life Associated With Immune Checkpoint Inhibitor Treatment for Mucosal Head and Neck Squamous Cell Carcinoma: A Scoping Review

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell   +11 more
wiley   +1 more source

“It's the Exact Same Treatment … Except Only 5 Min Away”: A RE‐AIM Evaluation of a Speech‐Language Pathology Shared‐Care Model for Rural Patients With Head and Neck Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Challenges accessing post‐treatment speech‐language pathology (SLP) services can add to treatment burden for rural patients with head and neck cancer (HNC). Hence, the aim of this study was to evaluate a shared‐care SLP service designed to support local SLP access for patients with HNC, using the RE‐AIM framework.
Corey Patterson   +7 more
wiley   +1 more source

Acute Medical Emergency Preparedness and Associated Factors in Community Pharmacies in Metro Manila, Philippines. [PDF]

open access: yesActa Med Philipp
Carandang RR   +5 more
europepmc   +1 more source

Metastasis-directed SBRT for oligometastatic hormone sensitive prostate cancer (METRO): protocol for a prospective randomised phase III trial, NCT04983095. [PDF]

open access: yesBMC Cancer
Söderkvist K   +21 more
europepmc   +1 more source

'Zero Alcohol Drinks Are Really Complex': Navigating Substitution and Addition Consumption Issues. [PDF]

open access: yesDrug Alcohol Rev
Pettigrew S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy